Indefinite Delivery Contract 36C26122D0054

Award Date 1/20/22
Last Date to Order 1/19/27
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
Cepheid has been awarded an indefinite delivery contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 to provide molecular reagents in support of the Genexpert Infinity system. The single award contract has a potential value of $1,000,000 and a period of performance through September 30, 2025. Under the contract, Cepheid has received a $319,984 firm fixed price delivery order to supply molecular reagents to two VA medical...
The U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 awarded a single-award indefinite delivery contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to procure reagents and test kits for the VA's GeneXpert diagnostic systems. The $3,783,614.55 delivery order contract has a performance period through March 31, 2025. Cepheid, as the original equipment manufacturer, will provide the VA with the necessary diagnostic consumables to support...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 (VA - VHA) awarded Cepheid a single award Indefinite Delivery Contract valued at up to $5,000,000 to provide molecular testing services. The contract utilizes an indefinite delivery/indefinite quantity structure with a period of performance through September 2028. Under the contract, Cepheid was issued a Firm Fixed Price delivery order valued at $786,443.51 to supply molecular testing from...
Cepheid has been awarded an indefinite delivery contract by the Department of Veterans Affairs Veterans Health Administration to provide molecular diagnostic solutions. The single award IDV has a potential value of $1,434,421.04 and period of performance through February 2026. As the prime contractor, Cepheid will supply its GeneXpert diagnostic testing equipment, associated reagents and consumables, as well as maintenance and support services. Delivery will be to VA medical facilities...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded Cepheid, located in San Antonio, Texas, an indefinite delivery contract with a potential value of $1,931,026.75 to provide Cepheid reagents and supplies. Under the contract, the agency has issued three firm fixed price delivery orders to Cepheid totaling $1,158,616.05 for reagents and supplies to support molecular diagnostic testing in South Texas veterans' healthcare facilities....
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 has awarded a Blanket Purchase Agreement (BPA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide CEPHEID REAGENTS, TEST KITS AND SUPPLIES. This single-award IDV contract has a ceiling value of $9,061,670.00 and a period of performance through September 30, 2025. The contract does not have a set-aside designation. Under this BPA, the VA has placed several task orders for Cepheid to...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a Blanket Purchase Agreement (BPA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide microbiology reagents, consumables, and related equipment for the VA's clinical testing programs. The contract has a potential value of $23,000,000 and a period of performance from October 2022 to October 2027. Under this BPA, Cepheid will supply a variety of diagnostic test kits, reagents, and...
The Department of Veterans Affairs (VA) has awarded Cepheid, a for-profit manufacturer of molecular diagnostic solutions, an Indefinite Delivery Contract (IDC) to provide reagents, test kits, and associated maintenance and support services to support the VA's clinical testing programs serving veterans. The contract, valued at up to $532,310.79, is a single-award IDC with the VA's Veterans Integrated Service Network 16 and does not have any set-aside designations. Under this IDC, the VA has...
The Department of Veterans Affairs (VA), Veterans Health Administration (VHA), Veterans Integrated Service Network 2 (VISN 2) awarded Cepheid, a for-profit manufacturer of molecular diagnostic solutions, a $518,924.36 firm fixed price Blanket Purchase Agreement (BPA) call contract to provide Cepheid's diagnostic testing products. The one-year contract, starting on September 11, 2023 and ending on September 10, 2024, will enable VISN 2 to continuously procure Cepheid's molecular diagnostic...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded Cepheid, a subsidiary of Danaher Corporation, a blanket purchase agreement call contract to provide reagents for laboratory testing services. The single award, firm-fixed price contract was awarded against Cepheid's Multiple Award Schedule contract and holds a potential value of approximately $565,957.60 over a five-year period of performance from October 2020 to September 2025....
  • 36C26122D0054
    Indefinite Delivery Contract
  • 4
    Federal Contract Awards

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded Cepheid, located in Palo Alto, California, an indefinite delivery contract with a potential value of $6,000,000 to provide Cepheid GeneXpert and GeneXpress reagents. Three firm fixed price delivery orders were subsequently awarded against this contract from 2022 through 2027, with values ranging from $409,119.60 to $933,262.29. The reagents support Cepheid's molecular diagnostic testing platforms used to conduct rapid diagnostic testing for infectious diseases at VA medical facilities within the specified network.

The original pre-solicitation notice indicated the VA's intent to award a noncompetitive contract directly to Cepheid as the sole source provider of reagents compatible with the agency's Cepheid GeneXpert and GeneXpress analyzers. No set-asides were applied. Performance will take place in Palo Alto, California. As a leading manufacturer of molecular diagnostic technologies, Cepheid is uniquely positioned to provide consumables that ensure continued operation of the VA's existing Cepheid equipment used for timely infectious disease screening of veterans receiving care.

Generated 1/26/24, 9:08 AM